Breaking News Instant updates and real-time market news.

BLK

BlackRock

$430.32

0.35 (0.08%)

09:27
03/22/19
03/22
09:27
03/22/19
09:27

BlackRock to acquire eFront for $1.3B in cash

BlackRock announced that it has made a binding offer and entered into an exclusive agreement, subject to the conditions below, to acquire 100% of the equity interests in eFront from private equity firm Bridgepoint and eFront employees, for $1.3B in cash. The combination of eFront with Aladdin, BlackRock's investment operating platform, will set a new standard in investment and risk management technology. eFront, which serves more than 700 clients in 48 countries, is a comprehensive technology solution for managing the alternatives investment lifecycle, from due diligence and portfolio planning to performance and risk analysis, across a range of alternative asset classes. As alternatives go mainstream, investment managers' ability to seamlessly manage portfolios across public and private asset classes on a single platform is critical. eFront will extend Aladdin's end-to-end processing solutions offering in alternative asset classes, enabling clients to get an enterprise view of their portfolio. Following completion of the notification and consultation process with eFront's employee-works council, as required by law, BlackRock and eFront's shareholders are expected to enter into a definitive securities sale agreement contemplated by the exclusive agreement. Closing of the transaction would be subject to entry into the definitive securities sale agreement and satisfaction of the conditions set forth therein. The eFront transaction will be funded with a combination of existing corporate liquidity and debt. While minimally dilutive to earnings per share, the transaction will not be dilutive on a cash basis.

  • 27

    Oct

BLK BlackRock
$430.32

0.35 (0.08%)

01/29/19
JEFF
01/29/19
UPGRADE
JEFF
Buy
BlackRock upgraded to Buy from Hold at Jefferies
Jefferies analyst Daniel Fannon upgraded BlackRock to Buy from Hold.
01/29/19
01/29/19
UPGRADE
Target $468

Buy
BlackRock upgraded to Buy on continued industry-leading growth at Jefferies
As previously reported, Jefferies analyst Daniel Fannon upgraded BlackRock to Buy from Hold, stating that it is benefiting from both structural shifts in investor behavior as well as secular trends and he believes the company can continue to deliver industry leading organic growth and capital return. Given the reset in earnings expectations, Fannon argues that the current risk/reward "is as attractive as it has been in 4 years." He raised his price target on BlackRock shares to $468 from $427.
01/29/19
01/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nvidia (NVDA) upgraded to Buy from Neutral at UBS with analyst Timothy Arcuri saying the 20% fiscal Q4 revenue miss preannounced and the stock drop "finally sets the stage for a new positive revision cycle starting this summer." 2. American Express (AXP) upgraded to Overweight from Neutral at Atlantic Equities. 3. BlackRock (BLK) upgraded to Buy from Hold at Jefferies with analyst Daniel Fannon saying it is benefiting from both structural shifts in investor behavior as well as secular trends and he believes the company can continue to deliver industry leading organic growth and capital return. 4. British American Tobacco (BTI) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying he views the stock's valuation as attractive at current levels and feels "modestly more comfortable" with Glo's patent litigation risk in Japan. 5. 3D Systems (DDD) and Stratasys (SSYS) were upgraded to Overweight from Neutral at Piper Jaffray. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/19
LEHM
03/14/19
NO CHANGE
Target $490
LEHM
Overweight
BlackRock price target raised to $490 from $472 at Barclays
Barclays analyst Jeremy Campbell raised his price target for BlackRock to $490 from $472 citing recent increases in assets under management. The analyst keeps an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

DXCM

DexCom

$154.45

-0.49 (-0.32%)

, ABT

Abbott

$83.56

0.35 (0.42%)

05:04
09/23/19
09/23
05:04
09/23/19
05:04
Recommendations
DexCom, Abbott analyst commentary  »

DexCom remains a…

DXCM

DexCom

$154.45

-0.49 (-0.32%)

ABT

Abbott

$83.56

0.35 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

  • 13

    Nov

EW

Edwards Lifesciences

$219.56

4.45 (2.07%)

04:58
09/23/19
09/23
04:58
09/23/19
04:58
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

, HON

Honeywell

$168.42

1.7 (1.02%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Downgrade
Illinois Tool Works, Honeywell rating change  »

Illinois Tool Works…

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

HON

Honeywell

$168.42

1.7 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

HR

Healthcare Realty Trust

$33.17

-0.155 (-0.47%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Healthcare Realty Trust management to meet with Capital One »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

NBIX

Neurocrine

$100.74

-0.77 (-0.76%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Neurocrine participates in a conference call with JPMorgan »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SIBN

SI-Bone

$20.18

0.28 (1.41%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
SI-Bone management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Texas Instruments management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

September PMI Composite…

CLDR

Cloudera

$9.00

0.33 (3.81%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Cloudera management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

IMAX

Imax

$21.83

0.04 (0.18%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Recommendations
Imax analyst commentary  »

Imax management to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

KNSL

Kinsale Capital Group

$99.46

-1.68 (-1.66%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Kinsale Capital Group management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

HKMPY

Hikma

$0.00

(0.00%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Hikma participates in a conference call with JPMorgan »

European Pharma Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 25

    Sep

DNOW

NOW Inc.

$12.05

-0.055 (-0.45%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
NOW Inc. management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 06

    Nov

  • 11

    Nov

  • 12

    Nov

  • 13

    Nov

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

PRGO

Perrigo

$55.29

0.995 (1.83%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Perrigo management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 01

    Oct

BRKR

Bruker

$43.62

0.06 (0.14%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Bruker management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

BABA

Alibaba

$182.43

1.96 (1.09%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Alibaba management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

ETSY

Etsy

$60.39

1.34 (2.27%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Etsy management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

SPOT

Spotify

$120.73

-3.685 (-2.96%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Spotify management to meet with Morgan Stanley »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

WTTR

Select Energy Services

$9.02

0.11 (1.23%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Select Energy Services management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Chicago Fed National Activity Index Level to be reported at 08:30 »

August Chicago Fed…

UPS

UPS

$120.71

1.61 (1.35%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
UPS management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

MTDR

Matador

$17.04

0.25 (1.49%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Matador management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.